261 related articles for article (PubMed ID: 8822340)
1. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
[TBL] [Abstract][Full Text] [Related]
2. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
Rhee Y; Won YY; Baek MH; Lim SK
J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
[TBL] [Abstract][Full Text] [Related]
5. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC; Kalu DN
J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
[TBL] [Abstract][Full Text] [Related]
6. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
[TBL] [Abstract][Full Text] [Related]
7. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats.
Zhang L; Endo N; Yamamoto N; Tanizawa T; Takahashi HE
Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616
[TBL] [Abstract][Full Text] [Related]
8. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
9. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
10. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
Cheng PT; Chan C; Müller K
J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
[TBL] [Abstract][Full Text] [Related]
11. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
12. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
[TBL] [Abstract][Full Text] [Related]
13. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
Nozaka K; Miyakoshi N; Kasukawa Y; Maekawa S; Noguchi H; Shimada Y
Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
[TBL] [Abstract][Full Text] [Related]
14. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
[TBL] [Abstract][Full Text] [Related]
15. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
16. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
17. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
[TBL] [Abstract][Full Text] [Related]
18. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis.
Fukata S; Hagino H; Okano T; Yamane I; Kameyama Y; Teshima R
Arthritis Rheum; 2004 Dec; 50(12):4060-9. PubMed ID: 15593226
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
20. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]